Intravascular ultrasound assessment of neointima distribution and the length of stent that was free of intravascular ultrasound-detectable intimal hyperplasia in paclitaxel-eluting stents

Gary S. Mintz, Myeongki Hong, Albert E. Raizner, Cheol Whan Lee, Jae Joong Kim, Esteban Escolar, Neal E. Fearnot, Seong Wook Park, Seung Jung Park, Neil J. Weissman

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Using data from the ASian Paclitaxel-Eluting Stent Clinical Trial, a 3-center, randomized, placebo-controlled trial of nonpolymeric paclitaxel-coated stents with a single center, 81-patient intravascular ultrasound (IVUS) substudy, the length of a stent that was free of IVUS-detectable intimal hyperplasia measured 3.2 ± 4.8 mm in placebo stents, 6.1 ± 5.6 mm in low-dose stents, and 8.7 ± 6.1 mm in high-dose stents (p = 0.0029). IVUS percent neointima volume obstruction correlated with the length of this IVUS neointima-free segment (r = 0.785, p <0.0001); angiographic late lumen loss and follow-up diameter stenosis also correlated with the IVUS neointima-free length of the stents (r = 0.670, p <0.0001 and r = 0.679, p <0.0001, respectively.

Original languageEnglish
Pages (from-to)107-109
Number of pages3
JournalAmerican Journal of Cardiology
Volume95
Issue number1
DOIs
Publication statusPublished - 2005 Jan 1

Fingerprint

Tunica Intima
Neointima
Paclitaxel
Hyperplasia
Stents
Placebos
Pathologic Constriction
Randomized Controlled Trials
Clinical Trials

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Mintz, Gary S. ; Hong, Myeongki ; Raizner, Albert E. ; Lee, Cheol Whan ; Kim, Jae Joong ; Escolar, Esteban ; Fearnot, Neal E. ; Park, Seong Wook ; Park, Seung Jung ; Weissman, Neil J. / Intravascular ultrasound assessment of neointima distribution and the length of stent that was free of intravascular ultrasound-detectable intimal hyperplasia in paclitaxel-eluting stents. In: American Journal of Cardiology. 2005 ; Vol. 95, No. 1. pp. 107-109.
@article{b724a1521e3c476b8c8834f0db48ddc0,
title = "Intravascular ultrasound assessment of neointima distribution and the length of stent that was free of intravascular ultrasound-detectable intimal hyperplasia in paclitaxel-eluting stents",
abstract = "Using data from the ASian Paclitaxel-Eluting Stent Clinical Trial, a 3-center, randomized, placebo-controlled trial of nonpolymeric paclitaxel-coated stents with a single center, 81-patient intravascular ultrasound (IVUS) substudy, the length of a stent that was free of IVUS-detectable intimal hyperplasia measured 3.2 ± 4.8 mm in placebo stents, 6.1 ± 5.6 mm in low-dose stents, and 8.7 ± 6.1 mm in high-dose stents (p = 0.0029). IVUS percent neointima volume obstruction correlated with the length of this IVUS neointima-free segment (r = 0.785, p <0.0001); angiographic late lumen loss and follow-up diameter stenosis also correlated with the IVUS neointima-free length of the stents (r = 0.670, p <0.0001 and r = 0.679, p <0.0001, respectively.",
author = "Mintz, {Gary S.} and Myeongki Hong and Raizner, {Albert E.} and Lee, {Cheol Whan} and Kim, {Jae Joong} and Esteban Escolar and Fearnot, {Neal E.} and Park, {Seong Wook} and Park, {Seung Jung} and Weissman, {Neil J.}",
year = "2005",
month = "1",
day = "1",
doi = "10.1016/j.amjcard.2004.08.072",
language = "English",
volume = "95",
pages = "107--109",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "1",

}

Intravascular ultrasound assessment of neointima distribution and the length of stent that was free of intravascular ultrasound-detectable intimal hyperplasia in paclitaxel-eluting stents. / Mintz, Gary S.; Hong, Myeongki; Raizner, Albert E.; Lee, Cheol Whan; Kim, Jae Joong; Escolar, Esteban; Fearnot, Neal E.; Park, Seong Wook; Park, Seung Jung; Weissman, Neil J.

In: American Journal of Cardiology, Vol. 95, No. 1, 01.01.2005, p. 107-109.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Intravascular ultrasound assessment of neointima distribution and the length of stent that was free of intravascular ultrasound-detectable intimal hyperplasia in paclitaxel-eluting stents

AU - Mintz, Gary S.

AU - Hong, Myeongki

AU - Raizner, Albert E.

AU - Lee, Cheol Whan

AU - Kim, Jae Joong

AU - Escolar, Esteban

AU - Fearnot, Neal E.

AU - Park, Seong Wook

AU - Park, Seung Jung

AU - Weissman, Neil J.

PY - 2005/1/1

Y1 - 2005/1/1

N2 - Using data from the ASian Paclitaxel-Eluting Stent Clinical Trial, a 3-center, randomized, placebo-controlled trial of nonpolymeric paclitaxel-coated stents with a single center, 81-patient intravascular ultrasound (IVUS) substudy, the length of a stent that was free of IVUS-detectable intimal hyperplasia measured 3.2 ± 4.8 mm in placebo stents, 6.1 ± 5.6 mm in low-dose stents, and 8.7 ± 6.1 mm in high-dose stents (p = 0.0029). IVUS percent neointima volume obstruction correlated with the length of this IVUS neointima-free segment (r = 0.785, p <0.0001); angiographic late lumen loss and follow-up diameter stenosis also correlated with the IVUS neointima-free length of the stents (r = 0.670, p <0.0001 and r = 0.679, p <0.0001, respectively.

AB - Using data from the ASian Paclitaxel-Eluting Stent Clinical Trial, a 3-center, randomized, placebo-controlled trial of nonpolymeric paclitaxel-coated stents with a single center, 81-patient intravascular ultrasound (IVUS) substudy, the length of a stent that was free of IVUS-detectable intimal hyperplasia measured 3.2 ± 4.8 mm in placebo stents, 6.1 ± 5.6 mm in low-dose stents, and 8.7 ± 6.1 mm in high-dose stents (p = 0.0029). IVUS percent neointima volume obstruction correlated with the length of this IVUS neointima-free segment (r = 0.785, p <0.0001); angiographic late lumen loss and follow-up diameter stenosis also correlated with the IVUS neointima-free length of the stents (r = 0.670, p <0.0001 and r = 0.679, p <0.0001, respectively.

UR - http://www.scopus.com/inward/record.url?scp=19944408197&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19944408197&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2004.08.072

DO - 10.1016/j.amjcard.2004.08.072

M3 - Article

VL - 95

SP - 107

EP - 109

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 1

ER -